Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Denlinger, Crystal S.; Sanft, Tara; Baker, K. Scott; Baxi, Shrujal S.; Broderick, Gregory A.; Demark‐Wahnefried, Wendy; Friedman, Debra L.; Goldman, Mindy; Hudson, Melissa M.; Khakpour, Nazanin; King, Allison A.; Koura, Divya; Kvale, Elizabeth; Lally, Robin M.; Langbaum, Terry S.; Melisko, Michelle; Montoya, José G.; Mooney, Kathi; Moslehi, Javid; O’Connor, Tracey; Overholser, Linda; Paskett, Electra D.; Peppercorn, Jeffrey; Rodriguez, Maria Alma; Ruddy, Kathryn J.; Silverman, Paula; Smith, Sophia K.; Syrjala, Karen L.; Tevaarwerk, Amye J.; Urba, Susan G.; Wakabayashi, Mark T.; Zee, Phyllis C.; Freedman-Cass, Deborah A.; McMillian, Nicole R.

doi:10.6004/jnccn.2017.0146

Cited by 102 publications

(98 citation statements)

References 274 publications

(204 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The life‐extending treatments offered to women with breast cancer often impair sexual function and quality of life (QOL) . Clinical cancer guidelines put forth by the National Comprehensive Cancer Network (NCCN) and the American Society for Clinical Oncology (ASCO) recommend that sexual function be addressed in patients with cancer along with other psychological and physical health issues . Yet, cancer clinicians infrequently raise the topic of sexual health with patients, and fewer than half of women with breast cancer receive any sexual health communication .…”

Section: Introductionmentioning

confidence: 99%

A brief intervention to enhance breast cancer clinicians' communication about sexual health: Feasibility, acceptability, and preliminary outcomes

et al. 2019

View full text Add to dashboard Cite

Objective Sexual concerns are often unaddressed for breast cancer patients; one reason is inadequate clinician training. We examined the feasibility, acceptability, and potential benefits of a novel intervention, improving Sexual Health and Augmenting Relationships through Education (iSHARE) for breast cancer clinicians. Methods Clinicians received training in communicating about sexual concerns with breast cancer patients. Intervention feasibility and acceptability were measured through enrollment/participation and postintervention program evaluations, respectively. Intervention effects were assessed through (1) clinician self‐reported beliefs about sexual health communication, assessed at baseline, post‐intervention, and 1‐ or 6‐month follow‐up, (2) clinical communication coded from audio recorded, transcribed clinic encounters at preintervention or postintervention, and (3) patient satisfaction with clinical care, reported immediately after the clinic visit. Patients also reported sociodemographic characteristics and level of sexual concerns. Results Seven breast cancer clinicians enrolled (88% participation), completed the intervention, and were audio recorded in clinic encounters with 134 breast cancer outpatients (67 each at preintervention or postintervention). Program evaluations supported intervention acceptability. Effect sizes suggest iSHARE increased clinicians' self‐efficacy (d = 0.27) and outcome expectancies for communicating about sexual concerns (d = 0.69) and reduced communication barriers (d = −0.14). Clinicians' sexual health communication behaviors increased from baseline to postintervention, including for raising the topic (28% vs 48%), asking questions (33% vs 45%), and offering information (18% vs 24%). Neither patient satisfaction nor duration of sexual health communication changed (mean duration less than 1 minute at both time points). Conclusions The iSHARE intervention was feasible and well received by clinicians and may change breast cancer clinicians' beliefs and communication behaviors regarding sexual health.

show abstract

Section: Introductionmentioning

confidence: 99%

A brief intervention to enhance breast cancer clinicians' communication about sexual health: Feasibility, acceptability, and preliminary outcomes

et al. 2019

View full text Add to dashboard Cite

show abstract

“…18,19 Thereafter, routine follow-up was performed according to our internal protocol based on the current international guidelines. 20 …”

Section: Methodsmentioning

confidence: 99%

Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings

Ursino¹,

Faggioni

Guidoccio³

et al. 2016

BJR

View full text Add to dashboard Cite

“…[1][2][3] Randomized controlled trials have strengthened the foundation in efficacy data for exercise in oncology; however, experimental designs can lack generalizability to a clinical setting (eg, homogeneity of the sample, exclusion of comorbid conditions, or willingness to be randomized). [1][2][3] Randomized controlled trials have strengthened the foundation in efficacy data for exercise in oncology; however, experimental designs can lack generalizability to a clinical setting (eg, homogeneity of the sample, exclusion of comorbid conditions, or willingness to be randomized).…”

Section: Introductionmentioning

confidence: 99%

Development, implementation, and effects of a cancer center's exercise‐oncology program

Mina

Auger

et al. 2019

Cancer

View full text Add to dashboard Cite

BACKGROUND: National and international bodies acknowledge the benefit of exercise for people with cancer, yet limited accessibility to related programing remains. Given their involvement in managing the disease, cancer centers can play a central role in delivering exercise-oncology services. The authors developed and implemented a clinically integrated exercise-oncology program at a major cancer center and evaluated its effectiveness and participant experience. METHODS: A hospital-based program with prescribed at-home exercise was developed and accepted referrals over a 42-month period (3.5 years). Implementation was conducted in 2 phases: a pilot phase for women with breast cancer and men with genitourinary cancer and a roll-out phase for all patients with cancer. Enrolled patients were assessed and received an exercise prescription as well as a program manual, resistance bands, and a stability ball from a kinesiologist. Program participation and effectiveness were evaluated up to 48 weeks after the baseline assessment using intention-to-treat analyses. Participants in the roll-out phase were asked to complete a program experience questionnaire at the completion of the 48-week follow-up. RESULTS: In total, 112 participants enrolled in the pilot, and 150 enrolled in the roll-out phase. Program attrition to 48 weeks was 48% and 65% in the pilot and roll-out phases, respectively. In participants who consented to research evaluation of their performance, objective and patient-reported measures of functional capacity improved significantly from baseline in both phases. Participants were highly satisfied with the program. CONCLUSIONS: Despite significant drop-out to program endpoints, our cancer-exercise program demonstrated clinically relevant improvement in functional outcomes and was highly appreciated by participants. Cancer 2019;125:3437-3447.

show abstract

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Cited by 102 publications

References 274 publications

A brief intervention to enhance breast cancer clinicians' communication about sexual health: Feasibility, acceptability, and preliminary outcomes

A brief intervention to enhance breast cancer clinicians' communication about sexual health: Feasibility, acceptability, and preliminary outcomes

Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings

Development, implementation, and effects of a cancer center's exercise‐oncology program

Contact Info

Product

Resources

About